Please login to the form below

Not currently logged in

Sanofi’s diabetes IMPACT programme wins at PMEA 2017

Takes home first place in Excellence in Demonstrating Economic and Societal Value


Sanofi celebrated a strong win last night at last night’s PMEA awards in London, earning a trophy in Excellence in Demonstrating Economic and Societal Value for its diabetes campaign.

‘IMPACT’, which was described by PMEA’s judges as “ambitious yet successful”, made a case for better diabetes control as the disease costs the NHS around £10bn annually.

The programme - which Sanofi worked on in collaboration with Diabetes UK and JDRF, a type 1 diabetes charity - went on to describe that 80% of these costs attribute to treating complications, which could potentially be reduced through improved blood glucose control.

PMEA’s judges said: “What was really impressive about this integrated project is that Sanofi successfully partnered with leading health economic groups.

“This programme was clearly articulated and coherent to resonate with all stakeholders.”

Run by PMLiVE’s publisher the PMGroup, PMEA exists to reward responsible customer-centric business practices that ensure treatments and advice provide patients with meaningful outcomes.

The programme has been specifically designed to recognise and commend excellence, best practice and innovation in local, European and international markets.

* See all the results from PMEA 2017

* View the PMEA 2017 photo gallery

Article by
Gemma Jones

16th November 2017

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech,...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...